Universität zu Köln

Al-Batran, Salah-Eddin, Homann, Nils, Pauligk, Claudia, Illerhaus, Gerald, Martens, Uwe M., Stoehlmacher, Jan, Schmalenberg, Harald, Luley, Kim B., Prasnikar, Nicole, Egger, Matthias, Probst, Stephan, Messmann, Helmut, Moehler, Markus, Fischbach, Wolfgang, Hartmann, Joerg T., Mayer, Frank, Hoeffkes, Heinz-Gert, Koenigsmann, Michael, Arnold, Dirk ORCID: 0000-0002-5325-8182, Kraus, Thomas W., Grimm, Kersten, Berkhoff, Stefan, Post, Stefan, Jager, Elke, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Ronellenfitsch, Ulrich, Moenig, Stefan and Hofheinz, Ralf D. (2017). Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer The AIO-FLOT3 Trial. JAMA Oncol., 3 (9). S. 1237 - 1245. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Hohloch, Karin, Zwick, Carsten, Ziepert, Marita, Hasenclever, Dirk, Kaiser, Ulrich, Engert, Andreas, Hoeffkes, Heinz-Gert, Kroschinsky, Frank, Mesters, Rolf, Feller, Andreas C., Loeffler, Markus, Truemper, Lorenz and Pfreundschuh, Michael (2014). Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL. SpringerPlus, 3. CHAM: SPRINGER INTERNATIONAL PUBLISHING AG. ISSN 2193-1801

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Altmann, Bettina, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Viardot, Andreas, Borchmann, Peter, Kanz, Lothar, Keller, Ulrich, Schmidt, Christian, Mahlberg, Rolf, Metzner, Bernd, Marks, Reinhard, Hoeffkes, Heinz-Gert, Christofyllakis, Konstantinos, Amam, Josif, Berdel, Christian, Stilgenbauer, Stephan, Schmitz, Norbert, Truemper, Lorenz, Murawski, Niels, Loeffler, Markus and Pfreundschuh, Michael (2018). Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Westphalen, C. Benedikt, Heinemann, Volker, Tessen, Hans Werner, Groschek, Matthias, Hoeffkes, Heinz-Gert, Marschner, Norbert, Schulze, Mathias, Beringer, Andreas and Waldschmidt, Dirk (2020). Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial. Z. Gastroent., 58 (4). S. 332 - 341. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-7803